Buy or sell FDNA stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

FDNA Stock

FDNA develops facial dysmorphology novel analysis technology solutions for healthcare professionals.

About FDNA Stock

FDNA develops facial dysmorphology novel analysis technology solutions for healthcare professionals. It offers a genetic search and reference tool called Face2Gene that facilitates detection of facial dysmorphic features and recognizable patterns of human malformations from a facial photo to present a list of matching syndromes with up-to-date references. FDNA's solution enables users to upload photos, search and review genetic resources, and analyze results and offers customized reports and visualization tools. Lior Wolf and Moti Shniberg founded it in 2011, with its headquarters in Boston in Massachusetts.

Management

Chief Scientific Advisor & Co-founder

Lior Wolf

CEO

Dekel Gelbman

Chairman & Co-founder

Moti Shniberg

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from FDNA or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo